Xeris Pharmaceuticals' Series C - II Round

Xeris Pharmaceuticals raised a round of funding on December 30, 2016.

Xeris is a specialty biopharmaceutical company focused on developing improved and differentiated injectable therapeutics for multiple indications in diabetes, epilepsy, and immunology. The company's X…

Articles about Xeris Pharmaceuticals' Series C - II Round: